BriaCell Therapeutics Corp. Financials
BCTX
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | JUL 2026 ~11.8:1 split | JUL 2025 ~1.4:1 split | JUL 2024 | JUL 2023 | JUL 2022 |
|---|---|---|---|---|---|
| General & Administrative | $7 | $6 | $6 | $8 | $7 |
| Research & Development | $29 | $21 | $27 | $15 | $8 |
| Total Operating Expenses | $36 | $27 | $33 | $23 | – |
| Operating Income | -$36 | -$27 | -$33 | -$23 | -$15 |
| Non-Operating | |||||
| Net Interest Expense | $1 | $0 | $0 | $1 | $0 |
| Other Non-Operating Income (Expense) | $71 | $54 | $38 | $43 | -$12 |
| EBT (Earnings Before Tax) | $35 | $27 | $5 | $20 | -$27 |
| Minority Interest | -$0 | -$0 | -$0 | – | – |
| Net Income | |||||
| Net Income | -$35 | -$26 | -$5 | -$20 | -$27 |
| EPS (Basic) | -$6.97 | -$62.19 | -$43.68 | -$195.00 | -$259.50 |
| EPS (Diluted) | -$6.97 | -$62.19 | -$43.68 | -$195.00 | -$259.50 |
| Weighted Avg Shares (Basic) | 5.0M | 423,114 | 16.5M | 15.6M | 15.5M |
| Weighted Avg Shares (Diluted) | 5.0M | 423,114 | 16.5M | 15.6M | 15.5M |
| Shares Outstanding | 5.0M | 423,114 | 109,699.547 | 104,131.173 | 103,293.94 |
BriaCell Therapeutics (BCTX) financials: revenue, profit and margins
BriaCell Therapeutics (BCTX) generated about n/a in revenue and -$35 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
Is BriaCell Therapeutics profitable?+
BriaCell Therapeutics reported about -$35 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
SourceFinancial statements computed from the 10-Q filed 28 Oct 2026, covering the period ending 31 Jul 2026, as reported to the SEC. Data last refreshed 29 Oct 2026. How this is calculated.
Fiscal year ends Jul.
Peers
Pharmaceutical Preparations · Pick stocks to compare with BCTX
Spot a number that looks wrong? Check it in BCTX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing BCTX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.